SCHEMBL3849548

SCHEMBL3849548

CCN1CCC(O)(c2ccc(Cl)c(OC(F)F)c2)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 13/20 0.43
OPRL1 P41146 7/20 0.43
OPRK1 P41145 7/20 0.42
OPRD1 P41143 7/20 0.42
DRD2 P14416 10/20 0.41
DRD4 P21917 9/20 0.41
DRD3 P35462 8/20 0.41
HTR1A P08908 6/20 0.41
HTR1D P28221 6/20 0.41
HTR2A P28223 6/20 0.41
HTR2C P28335 6/20 0.41
HTR7 P34969 6/20 0.41
DRD1 P21728 5/20 0.41
DRD5 P21918 5/20 0.41
SLC6A2 P23975 5/20 0.41
SLC6A4 P31645 5/20 0.41
HTR2B P41595 5/20 0.41
HTR6 P50406 5/20 0.41
SLC6A3 Q01959 5/20 0.41
HRH2 P25021 5/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3850813 0.91 OPRM1 (0.46) OPRM1OPRL1OPRK1OPRD1DRD2
SCHEMBL3857797 0.86 SSTR5 (0.41) OPRL1DRD2DRD3HTR1AHTR2A
SCHEMBL3861370 0.83 OPRM1 (0.48) OPRM1OPRL1OPRK1OPRD1DRD2
SCHEMBL3849571 0.82 PDE4A (0.41) OPRM1OPRL1OPRK1OPRD1SLC6A2
SCHEMBL3852309 0.80 DRD2 (0.54) OPRM1OPRL1OPRK1OPRD1DRD2
SCHEMBL3853387 0.79 OPRL1 (0.51) OPRM1OPRL1OPRK1OPRD1DRD2
SCHEMBL3853201 0.77 SSTR5 (0.44) OPRM1OPRL1DRD2DRD3HTR1A
SCHEMBL3857772 0.77 OPRL1 (0.48) OPRM1OPRL1OPRK1OPRD1DRD2
SCHEMBL3859039 0.76 OPRM1 (0.70) OPRM1OPRL1OPRK1OPRD1DRD2
SCHEMBL3850817 0.76 DRD2 (0.42) OPRM1OPRL1OPRK1OPRD1DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101076517-A Novel substituted piperidines as modulators of dopamine neurotransmission CARLSSON A RESEARCH AB (SE) 2007-11-21 CN claimed
CN-101076517-B Substituted piperidines as modulators of dopamine neurotransmission NSAB AF NEUROSEARCH SWEDEN AB 2010-12-15 CN disclosed
US-7579474-B2 Substituted piperidines as modulators of dopamine neurotransmission NSAB, FILIAL AF NEUROSEARCH AB, SVERIGE (DK) 2009-08-25 US disclosed
US-20070270467-A1 SUBSTITUTED PIPERIDINES AS MODULATORS OF DOPAMINE NEUROTRANSMISSION NSAB, FILIAL AF NEUROSEARCH SWEDEN AB, SVERIGE (DK) 2007-11-22 US disclosed
CN-101076517-A Novel substituted piperidines as modulators of dopamine neurotransmission CARLSSON A RESEARCH AB (SE) 2007-11-21 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070270467-A1 SUBSTITUTED PIPERIDINES AS MODULATORS OF DOPAMINE NEUROTRANSMISSION DRD2, PRLHR, DRD3 OPRM1 35/4885OPRL1 9/4885OPRK1 11/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.